Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NorCAPITAL clonidine in adolescents with CFS/ME
2009-016924-30Phase 2Completed
- Sponsor
- Rikshospitalet
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myalgic encephalomyelitis (ME) comparing clonidine (Catapresan) with placebo (2 arms). Primary endpoint: Mean steps/day at 8 weeks. Started Nov 2009; status: completed.
02
Drugs
clonidine
03
Conditions
myalgic encephalomyelitis (ME)
Beyond the preview
Go deeper on 2009-016924-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016924-30.